The licensing agreement is for two promising metabolites with the potential to significantly improve metabolic health and naturally address the obesity epidemic by filling a crucial void left by GLP-1 drugs. DOVER, Del., July 30, 2024 /PRNewswire/ — Metabolize, a breakthrough solution to…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.